Diseases [C] » Eye Diseases [C11] » Lacrimal Apparatus Diseases » Dry Eye Syndromes
Description
Corneal and conjunctival dryness due to deficient tear production, predominantly in menopausal and post-menopausal women. Filamentary keratitis or erosion of the conjunctival and corneal epithelium may be caused by these disorders. Sensation of the presence of a foreign body in the eye and burning of the eyes may occur. MeSH
Hierarchy View
Subtype Terms (3)
Keratoconjunctivitis Sicca
28 drugs (17 approved, 11 experimental)
Sjogren's Syndrome
109 drugs (46 approved, 63 experimental)
Xerophthalmia
3 drugs (2 approved, 1 experimental)
Approved Indicated Drugs (15)
Phase 4 Indicated Drugs (44)
Phase 3 Indicated Drugs (30)
Phase 2 Indicated Drugs (51)
Other Experimental Indicated Drugs (30)
Organization Involved with Phase 4 Indications (76)
Coastal Connecticut Research, LLC
Eye and Vision Technologies and Research Institute
Federal University of Rio de Janeiro
Florida Eye Microsurgical Institute, Inc.
Hospital Nacional Profesor Alejandro Posadas
Icahn School of Medicine at Mount Sinai
Innovative Medical Research of South Florida, Inc
Instituto Universitario de Oftalmobiología Aplicada
Laboratorios Sophia S.A de C.V.
Ophthalmic Consultants of Long Island
PRN Pharmacuetical Research Network, LLC
Samil Pharmaceutical Co., Ltd.
Schepens Eye Research Institute
Organization Involved with Phase 3 Indications (69)
Abrams Eye Center, Cleveland, OH
Chattanooga Eye Institute, Chattanooga, TN
C.T. Development America, Inc.
Federal University of Sao Paulo
Korea Institute of Oriental Medicine
Physician Recommended Nutriceuticals
Pontificia Universidad Catolica de Chile
Organization Involved with Phase 2 Indications (63)
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (37)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
